The OPM breach was a wake-up call. It showed everyone how important it is to be super careful with security *before* ...

The Canadian VPN provider doesn't know why, only that it's in connection with an investigation. However, Windscribe maintains ...

German factory orders unexpectedly posted their biggest rise in two years in December, official data showed Thursday, fuelling hopes that a turnaround is taking hold in Europe's struggling top economy ...

Just the same, there are many legitimate reasons why you don’t want an outside entity monitoring your internet activity. Your ...

At least 180,000 hospitalizations have been recorded, CDC data shows. Flu activity remains elevated throughout the United States, with children being hit especially hard, according to newly released ...

Flu activity is continuing to climb across the U.S. as hospitalizations rise, according to newly released data from the Centers for Disease Control and Prevention. The percent of outpatient visits for ...

There have been at least 120,0000 hospitalizations so far, the CDC says. Flu activity is continuing to climb across the U.S. as hospitalizations rise, according to newly released data from the Centers ...

Update: Article updated to reflect that the ShinyHunters says they were not involved in this activity. We have updated our story and title. Threat actors associated with the "Scattered Lapsus$ Hunters ...

Please provide your email address to receive an email when new articles are posted on . Physical activity rates were significantly lower on days when patients underwent hemodialysis. Rates were lowest ...

Factory activity returned to expansion after nine months of contraction. Manufacturing outperformed forecasts, signaling stabilizing demand. Large firms drove gains, while smaller businesses stayed ...

Onchain data shows activity holding up on Ethereum, Polygon, Arbitrum and Avalanche even as fee revenue declines across the crypto sector. Several of the biggest blockchain networks handled more ...

Altimmune (ALT) on Friday announced initial results from a mid-stage trial for its lead asset pemvidutide in metabolic dysfunction-associated steatohepatitis (MASH), noting that the GLP-1 drug led to ...